Search by Drug Name or NDC
NDC 59011-0960-10 NALMEFENE HYDROCHLORIDE 1 mg/mL Details
NALMEFENE HYDROCHLORIDE 1 mg/mL
NALMEFENE HYDROCHLORIDE is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Purdue Pharma L.P.. The primary component is NALMEFENE HYDROCHLORIDE.
Product Information
| NDC | 59011-0960 |
|---|---|
| Product ID | 59011-960_497b844c-417a-4d6c-8eac-d4f276fdd7f5 |
| Associated GPIs | 93400018102040 |
| GCN Sequence Number | 083210 |
| GCN Sequence Number Description | nalmefene HCl VIAL 2 MG/2 ML INJECTION |
| HIC3 | H3T |
| HIC3 Description | OPIOID ANTAGONISTS |
| GCN | 52106 |
| HICL Sequence Number | 010052 |
| HICL Sequence Number Description | NALMEFENE HCL |
| Brand/Generic | Generic |
| Proprietary Name | NALMEFENE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | NALMEFENE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | NALMEFENE HYDROCHLORIDE |
| Labeler Name | Purdue Pharma L.P. |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212955 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59011-0960-10 (59011096010)
| NDC Package Code | 59011-960-10 |
|---|---|
| Billing NDC | 59011096010 |
| Package | 10 VIAL, GLASS in 1 CARTON (59011-960-10) / 2 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2022-02-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |